Etanercept plus methylprednisolone as initial therapy for acute graft-versus-host disease

Graft-versus-host disease (GVHD) is a principal cause of morbidity following allogeneic hematopoietic cell transplantation (HCT). Standard therapy for GVHD, high-dose steroids, results in complete responses (CRs) in 35% of patients. Because tumor necrosis factor-α (TNFα) is an important effector of...

Description complète

Enregistré dans:
Détails bibliographiques
Auteurs principaux: Levine, John E., Paczesny, Sophie, Mineishi, Shin, Braun, Thomas, Choi, Sung W., Hutchinson, Raymond J., Jones, Dawn, Khaled, Yasser, Kitko, Carrie L., Bickley, Daniel, Krijanovski, Oleg, Reddy, Pavan, Yanik, Gregory, Ferrara, James L. M.
Format: Artigo
Langue:Inglês
Publié: American Society of Hematology 2008
Sujets:
Transplantation
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC2361693/
https://ncbi.nlm.nih.gov/pubmed/18042798
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1182/blood-2007-09-112987
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires